Diabetes is huge problem for Americans. Source: BioSpace

Kenneth Pittman, writing for Seeking Alpha, takes a look at why Shire is thinking of unloading its neuroscience division and suggesting an alternative. Source: BioSpace

The agreement, whose final terms are still being negotiated, must be approved by a court. Source: BioSpace

Eli Lilly continues to make investments in its diabetes business. Source: BioSpace

Genentech is claiming that Pfizer's proposed biosimilar infringes 40 of its patents. Source: BioSpace

A number of biopharma companies are making strides in developing non-opioid pain killers or opioids that are more difficult to abuse. Source: BioSpace

Keith Speights, writing for The Motley Fool, notes one biotech that's booming. Source: BioSpace

The price of a single pill went up from 16p to 9.22 pounds, even though production costs remained broadly stable during that period, the CMA said. Source: BioSpace

HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace

Both Amazon and Rite Aid offered no comment for this story. Source: BioSpace